Mucormycosis in Systemic Lupus Erythematosus

Seminars in Arthritis and Rheumatism

Volumn 33, Issue 2, 2003, Pages 115-124

  Mok, Chi Chiu ^a   Que, Tak Lun ^a   Tsui, Edmund Yik Kong ^a   Lam, Wing Yin ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Fungal; Infection; Morbidity; Opportunistic; Zygomycosis

Indexed keywords

ADULT; AUTOPSY; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MUCORMYCOSIS; NOSE CAVITY; PARANASAL SINUS; PRIORITY JOURNAL; REVIEW; RHIZOPUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0242410676     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(03)00081-7     Document Type: Article

References (63)

1. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001;13:345-51.
2. Mok CC, Lee KW, Ho CTK, Lau CS, Wong RWS. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 2000;39:399-406.
3. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000;27:685-91.
4. Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: A population based study. J Rheumatol 2000;27:1884-91.
5. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982;25:612-7.
6. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1999;78:167-75.
7. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 2002;61:409-13.
8. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infection: A controlled and prospective study including an epidemiological group. Q J Med 1985;55:271-87.
9. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 1998;24:423-56.
10. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) 1987;66:341-8.
11. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: The bimodal pattern revisited. Q J Med 1985;55:87-98.
12. Staples PJ, Gerding DN, Decker JL, Gordon RS Jr. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974;17:1-10.
13. Mok CC, Yuen KY, Lau CS. Nocardiosis in systemic lupus erythematosus. Semin Arthritis Rheum 1997;26:675-83.
14. Gonzalez-Crespo MR, Gomez-Reino JJ. Invasive aspergillosis in systemic lupus erythematosus. Semin Arthritis Rheum 1995;24:304-14.
15. Katz A, Ehrenfeld M, Livneh A, Bank I, Gur H, Pauzner R, et al. Aspergillosis in systemic lupus erythematosus. Semin Arthritis Rheum 1996;26:635-40.
16. Mok CC, Lau CS, Yuen KY. Cryptococcal meningitis presenting concurrently with systemic lupus erythematosus. Clin Exp Rheumatol 1998;16:169-71.
17. Johnson WM, Gall EP. Fatal coccidioidomycosis in collagen vascular diseases. J Rheumatol 1983;10:79-84.
18. Richardson MD, Shankland GS. Rhizopus, Rhizomucor, Absidia, and other agents of systemic and subcutaneous zygomycoses. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH eds. Manual of Clinical Microbiology. Washington, DC: ASM Press, 1999;1242-58.
19. Wong KL, Tai YT, Loke SL, Woo EK, Wong WS, Chan MK, et al. Disseminated zygomycosis masquerading as cerebral lupus erythematosus. Am J Clin Pathol 1986;86:546-9.
20. Fingerote RJ, Seigel S, Atkinson MH, Lewkonia RM. Disseminated zygomycosis associated with systemic lupus erythematosus. J Rheumatol 1990;17:1692-4.
21. Bloxham CA, Carr S, Ryan DW, Kesteven PJ, Bexton RS, Griffiths ID, et al. Disseminated zygomycosis and systemic lupus erythematosus. Intensive Care Med 1990;16:201-7.
22. Escobar A, Del Brutto OH. Multiple brain abscesses from isolated cerebral mucormycosis. J Neurol Neurosurg Psychiatry 1990;53:431-3.
23. Dickinson M, Kalayanamit T, Yang CA, Pomper GJ, Franco-Webb C, Rodman D. Cutaneous zygomycosis (mucormycosis) complicating endotracheal intubation: Diagnosis and successful treatment. Chest 1998;114:340-2.
24. Hosseini M, Lee J. Gastrointestinal mucormycosis mimicking ischemic colitis in a patient with systemic lupus erythematosus. Am J Gastroenterol 1998;93:1360-2.
25. Liu MF, Chen FF, Hsiue TR, Liu CC. Disseminated zygomycosis simulating cerebrovascular disease and pulmonary alveolar hemorrhage in a patient with systemic lupus erythematosus. Clin Rheumatol 2000;19:311-4.
26. Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ. Mucormycosis. UCLA Conference. Ann Intern Med 1980;93:93-108.
27. Brown SR, Shah IA, Grinstead M. Rhinocerebral mucormycosis caused by Apophysomyces elegans. Am J Rhinol 1998;12:289-92.
28. Burrell SR, Ostlie DJ, Saubolle M, Dimler M, Barbour SD. Apophysomyces elegans infection associated with cactus spine injury in an immunocompetent pediatric patient. Pediatr Infect Dis J 1998;17:663-4.
29. Radner AB, Witt MD, Edwards JE Jr. Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin Infect Dis 1995;20:163-6.
30. Solano T, Atkins B, Tambosis E, Mann S, Gottlieb T. Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis 2000;30:942-3.
31. Gartenberg G, Bottone EJ, Keusch GT, Weitzman I. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: Epidemiology, mycology and treatment. N Engl J Med 1978;299:1115-8.
32. Sugar AM. Mucormycosis. Clin Infect Dis 1992;14(suppl 1):S126-9.
33. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000;30:851-6.
34. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: The last 30 years. Arch Intern Med 1999;159:1301-9.
35. Andrews DR, Allan A, Larbalestier RI. Tracheal mucormycosis. Ann Thorac Surg 1997;63:230-2.
36. Husari AW, Jensen WA, Kirsch CM, Campagna AC, Kagawa FT, Hamed KA, et al. Pulmonary mucormycosis presenting as an endobronchial lesion. Chest 1994;106:1889-91.
37. Maddox L, Long GD, Vredenburgh JJ, Folz RJ. Rhizopus presenting as an endobronchial obstruction following bone marrow transplant. Bone Marrow Trans 2001;28:634-6.
38. Cherney CL, Chutuape A, Fikrig MK. Fatal invasive gastric mucormycosis occurring with emphysematous gastritis: case report and literature review. Am J Gastroenterol 1999;94:252-6.
39. Blair JE, Fredrikson U, Pockaj BA, Lucaire CS. Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test. Mayo Clin Proc 2002;77:717-20.
40. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 1984;74:150-60.
41. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am 2000;33:349-65.
42. Chinn RY, Diamond RD. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: Relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun 1982;38:1123-9.
43. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001;44:253-60.
44. Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 1972;77:871-9.
45. Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: A retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto). Br J Haematol 1997;99:331-6.
46. Mondy KE, Haughey B, Custer PL, Wippold FJ II, Ritchie DJ, Mundy LM. Rhinocerebral mucormycosis in the era of lipid-based amphotericin B: case report and literature review. Pharmacotherapy 2002;22:519-26.
47. Wehl G, Hoegler W, Kropshofer G, Meister B, Fink FM, Heitger A. Rhinocerebral mucormycosis in a boy with recurrent acute lymphoblastic leukemia: Long-term survival with systemic antifungal treatment. J Pediatr Hematol Oncol 2002;24:492-4.
48. Alleyne CH Jr, Vishteh AG, Spetzler RF, Detwiler PW. Long-term survival of a patient with invasive cranial base rhinocerebral mucormycosis treated with combined endovascular, surgical, and medical therapies: Case report. Neurosurgery 1999;45:1461-3.
49. Weprin BE, Hall WA, Goodman J, Adams GL. Long-term survival in rhinocerebral mucormycosis. Case report. J Neurosurg 1998;88:570-5.
50. Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 1988;10:551-9.
51. De La Paz MA, Patrinely JR, Marines HM, Appling WD. Adjunctive hyperbaric oxygen in the treatment of bilateral cerebro-rhino-orbital mucormycosis. Am J Ophthalmol 1992;114:208-11.
52. Kobayashi M, Hiruma M, Matsushita A, Kawai M, Ogawa H, Udagawa S. Cutaneous zygomycosis: A case report and review of Japanese reports. Mycoses 2001;44:311-5.
53. Blair JE, Fredrikson LJ, Pockaj BA, Lucaire CS. Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test. Mayo Clin Proc 2002;77:717-20.
54. Talmi YP, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M, Horowitz Z, et al. Rhino-orbital and rhinoorbito-cerebral mucormycosis. Otolaryngol Head Neck Surg 2002;127:22-31.
55. Rangel-Guerra RA, Martinez HR, Saenz C, Bosques-Padilla F, Estrada-Bellmann I. Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases. J Neurol Sci 1996;143:19-30.
56. Cuvelier I, Vogelaers D, Peleman R, Benoit D, Van Marck V, Offner F, et al. Two cases of disseminated mucormycosis in patients with hematological malignancies and literature review. Eur J Clin Microbiol Infect Dis 1998;17:859-63.
57. Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044-50.
58. Kammer GM, Perl A, Richardson BC, Tsokos GC. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum 2002;46:1139-54.
59. Scheinecker C, Zwolfer B, Koller M, Manner G, Smolen JS. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum 2001;44:856-65.
60. Kojo S, Adachi Y, Keino H, Taniguchi M, Sumida T. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum 2001;44:1127-38.
61. Piliero P, Furie R. Functional asplenia in systemic lupus erythematosus. Semin Arthritis Rheum 1990;20:185-9.
62. Davies KA, Robson MG, Peters AM, Norsworthy P, Nash JT, Walport MJ. Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus. Arthritis Rheum 2002;46:1028-38.
63. Nived O, Linder C, Odeberg H, Svensson B. Reduced opsonisation of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus. Ann Rheum Dis 1985;44:252-9.